These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34014011)

  • 1. Development and validation of the Physician's Global Assessment of Fingernail Psoriasis.
    Hudgens S; Rich P; Geng Z; Williams D; Fleischer A; Ganguli A
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):2324-2330. PubMed ID: 34014011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Physician's Global Assessment of Fingernail Psoriasis by Rheumatologists Treating Psoriatic Arthritis.
    Hudgens S; Gugiu C; Guobyte A; Soliman AM; Fitzgerald KA; Barcomb LM; Eldred AK; Okun MM
    Value Health; 2022 Sep; 25(9):1582-1589. PubMed ID: 35623975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
    Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD
    Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.
    Berth-Jones J; Grotzinger K; Rainville C; Pham B; Huang J; Daly S; Herdman M; Firth P; Hotchkiss K
    Br J Dermatol; 2006 Oct; 155(4):707-13. PubMed ID: 16965419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.
    Bożek A; Reich A
    Adv Clin Exp Med; 2017 Aug; 26(5):851-856. PubMed ID: 29068583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index.
    Berth-Jones J; Thompson J; Papp K;
    Br J Dermatol; 2008 Aug; 159(2):407-12. PubMed ID: 18565187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials.
    Foley P; Gordon K; Griffiths CEM; Wasfi Y; Randazzo B; Song M; Li S; Shen YK; Blauvelt A
    JAMA Dermatol; 2018 Jun; 154(6):676-683. PubMed ID: 29799960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial.
    Elewski BE; Baker CS; Crowley JJ; Poulin Y; Okun MM; Calimlim B; Geng Z; Reyes Servin O; Rich PA
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2168-2178. PubMed ID: 31304993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity.
    Cappelleri JC; Bushmakin AG; Harness J; Mamolo C
    Qual Life Res; 2013 Nov; 22(9):2489-99. PubMed ID: 23475691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment.
    Langley RG; Ellis CN
    J Am Acad Dermatol; 2004 Oct; 51(4):563-9. PubMed ID: 15389191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 1 of 2): change during therapy in Psoriasis Area and Severity Index, Static Physician's Global Assessment and Lattice System Physician's Global Assessment.
    Chow C; Simpson MJ; Luger TA; Chubb H; Ellis CN
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1406-14. PubMed ID: 25917315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature.
    Puzenat E; Bronsard V; Prey S; Gourraud PA; Aractingi S; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Paul C; Richard-Lallemand MA; Ortonne JP; Aubin F
    J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():10-6. PubMed ID: 20443995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 2 of 2): use of quality of life to assess construct validity of the Lattice System Physician's Global Assessment, Psoriasis Area and Severity Index and Static Physician's Global Assessment.
    Simpson MJ; Chow C; Morgenstern H; Luger TA; Ellis CN
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1415-20. PubMed ID: 25917214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).
    Mahil SK; Wilson N; Dand N; Reynolds NJ; Griffiths CEM; Emsley R; Marsden A; Evans I; Warren RB; Stocken D; Barker JN; Burden AD; Smith CH;
    Br J Dermatol; 2020 May; 182(5):1158-1166. PubMed ID: 31286471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies.
    Callis Duffin K; Bushmakin AG; Cappelleri JC; Mallbris L; Mamolo C
    BMC Dermatol; 2019 Jun; 19(1):8. PubMed ID: 31174539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a simple measure of psoriasis severity based on a longitudinal study of Chinese patients.
    Cao D; Shen M; Chen X; Xiao Y; Lu W; Luo Y; Zhu W; Kuang Y
    Eur J Dermatol; 2020 Dec; 30(6):674-679. PubMed ID: 33459259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the Physician Global Assessment in a clinical setting to measure and track patient outcomes.
    Pascoe VL; Enamandram M; Corey KC; Cheng CE; Javorsky EJ; Sung SM; Donahue KR; Kimball AB
    JAMA Dermatol; 2015 Apr; 151(4):375-81. PubMed ID: 25549367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interobserver reliability of the Nail Psoriasis Severity Index.
    Aktan S; Ilknur T; Akin C; Ozkan S
    Clin Exp Dermatol; 2007 Mar; 32(2):141-4. PubMed ID: 17137477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in paediatric cutaneous lupus among paediatric dermatologists and rheumatologists.
    Kushner CJ; Tarazi M; Gaffney RG; Feng R; Ardalan K; Brandling-Bennett HA; Castelo-Soccio L; Chang JC; Chiu YE; Gmuca S; Hunt RD; Kahn PJ; Knight AM; Mehta J; Pearson DR; Treat JR; Wan J; Yeguez AC; Concha JSS; Patel B; Okawa J; Arkin LM; Werth VP
    Br J Dermatol; 2019 Jan; 180(1):165-171. PubMed ID: 30033560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global assessment of psoriasis severity and change from photographs: a valid and consistent method.
    Farhi D; Falissard B; Dupuy A
    J Invest Dermatol; 2008 Sep; 128(9):2198-203. PubMed ID: 18418412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.